1. AB0341 SURVIVAL OF REMISSION OR LOW DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB. RESULTS OF RUSSIAN NATIONAL REGISTER. (2nd June 2020) Authors: Gaydukova, I.; Mazurov, V.; Lila, A.; Baranov, A.; Lukina, G.; Babaeva, A.; Kalinina, E.; Salnikova, T.; Sorotskaya, V.; Samigullina, R.; Chakieva, D.; Grabovetskaya, I.; Marusenko, I.; Gaydukova, E.; Nasonov, E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0206 А VERY EARLY (7-28 DAYS) RESPONSE ON JAK INHIBITOR TOFACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: EFFECT ON PAIN AND CENTRAL SENSITIZATION. (13th June 2020) Authors: Karateev, A.; Filatova, E.; Pogozheva, E.; Amirdzhanova, V.; Nasonov, E.; Lila, A.; Mazurov, V.; Lapkina, N.; Lukina, G.; Salnikova, T.; Samigullina, R.; Chakieva, D.; Marusenko, I.; Semagina, O.; Semchenkova, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗